Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo‐controlled trial

Abstract Background and Aims: Cocaine use disorder (CUD) is a significant public health concern for which no efficacious pharmacological interventions are available. Cannabidiol (CBD) has attracted considerable interest as a promising treatment for addiction. This study tested CBD efficacy for reducing craving and preventing relapse in people with CUD. Design: Single‐site double‐blind randomized controlled superiority trial comparing CBD with placebo. Setting and Participants: Centre Hospitalier de l’Université de Montréal, Canada. Seventy‐eight adults (14 women) with moderate to severe CUD participated.